Widely prescribed, newer-generation antipsychotic drugs are no more effective for the treatment of schizophrenia in children and teens than older, cheaper drugs, a government-funded study shows.
Under the direction of the National Institute of Mental Health (NIMH), researchers compared two of the newer drugs, known as atypical antipsychotics, to an older-generation antipsychotic. They found no major differences in treatment outcomes, but big differences in side effects among young patients taking the newer and older drugs.
Newer Antipsychotics No Better in Kids
A group of 14 law firms representing nearly 20,000 plaintiffs is seeking to intervene in Bayer’s...
As marijuana use among teens has grown in the past decade, researchers have been trying to...
The Food and Drug Administration Monday unveiled the details of a new policy designed to make...
